Showing results (581-590 of 603) with videos related to

Sort By:
Pageof 61
EFSA Journal. European Food Safety Authority|November 3, 2021
Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed. Part 11: Sulfonamides, Konstantinos Koutsoumanis, Ana Allende, et al.
EFSA Journal. European Food Safety Authority|November 3, 2021
Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed. Part 13: Diaminopyrimidines: trimethoprim, Konstantinos Koutsoumanis, Ana Allende, et al.
EFSA Journal. European Food Safety Authority|November 3, 2021
Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed. Part 6: Macrolides: tilmicosin, tylosin and tylvalosin, Konstantinos Koutsoumanis, Ana Allende, et al.
EFSA Journal. European Food Safety Authority|November 3, 2021
Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed. Part 7: Amphenicols: florfenicol and thiamphenicol, Konstantinos Koutsoumanis, Ana Allende, et al.
EFSA Journal. European Food Safety Authority|November 3, 2021
Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed. Part 9: Polymyxins: colistin, Konstantinos Koutsoumanis, Ana Allende, et al.
EFSA Journal. European Food Safety Authority|November 3, 2021
Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed. Part 2: Aminoglycosides/aminocyclitols: apramycin, paromomycin, neomycin and spectinomycin, Ana Allende, Konstantinos Koutsoumanis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 27, 2025
Prognostic Value of FDG PET Metabolic Parameters Before and After 42 Gy of Radiochemotherapy in Patients with Inoperable Stage III Nonsmall Cell Lung CancerPierre Vera, Philippe Giraud, Sébastien Hapdey, et al.
EFSA Journal. European Food Safety Authority|January 30, 2025
Preparedness, prevention and control related to zoonotic avian influenza, , Julio Alvarez, et al.
Pediatric Blood & Cancer|January 21, 2026
Investigating Biomarkers for Inborn Errors of Immunity in a Prospective Study of Patients With Autoimmune CytopeniaZsuzsanna Gaál, Cristina Meehan, Melis Yilmaz, et al.
Nature Immunology|July 28, 2022
Partial RAG deficiency in humans induces dysregulated peripheral lymphocyte development and humoral tolerance defect with accumulation of T-bet+ B cellsKrisztian Csomos, Boglarka Ujhazi, Peter Blazso, et al.
Pageof 61